Cellphire Therapeutics Reveals Cryptics Phase 2/3 Study Topline
01 Oct 2025 //
GLOBENEWSWIRE
Cellphire Therapeutics Stops CRYPTICS Phase 2/3 Study Early
22 Apr 2025 //
GLOBENEWSWIRE
Cellphire Therapeutics CLPH-511 Fast Track Designation Granted
17 Mar 2025 //
GLOBENEWSWIRE
				
				 
				  			
 Market Place
 Sourcing Support